Greg Divis

Greg Divis serves as Chief Executive Officer at Avadel Pharmaceuticals plc. Avadel Pharmaceuticals plc operates in the research sector with approximately 220.0 employees. The company is headquartered in Chesterfield, Missouri. Avadel Pharmaceuticals plc generates annual revenue of 169100000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 1,625 executive contacts are available in Missouri.
• • Our database includes 201,469 c suite-level executives.

Amazon CloudFront Route 53 Mailchimp Mandrill Outlook Microsoft Office 365 Amazon AWS Pardot Microsoft Azure Google Analytics Mobile Friendly Akamai RUM Google Tag Manager New Relic Google Font API Data Analytics Remote

unapproved marketed drugs controlled & extended release sleep disorders oral & injectable drugs pediatric & geriatric medicines abuse deterrent formulation drug delivery platforms formulation & cmc development biotechnology: pharmaceutical preparations health care biotechnology research narcolepsy cataplexy excessive daytime sleepiness eds sodium oxybate lumryz cns depressant fda approval extended-release clinical trials sleep disorder sleep paralysis respiratory depression rem sleep pivotal phase 3 study rems program adverse reactions drug interactions psychiatric effects patient safety pediatric narcolepsy adult narcolepsy opioid analgesics benzodiazepines anxiety depression suicidal ideation sodium content enuresis sleepwalking drug dependence withdrawal symptoms neurological disorders serious medical problems pharmaceutical development orphan drug designation innovation patient experience healthcare professionals clinical effectiveness patient advocacy treatment options biopharmaceutical risk evaluation & mitigation immediate-release psychotic symptoms emotional disorder behavioral reactions patient-centered care biopharmaceuticals innovative treatments specialty pharmaceuticals patient-centric unmet medical needs hospital settings injectable drugs chronic care acute care healthcare providers patient outcomes drug development orphan drug status commercial focus treatment paradigms healthcare accessibility specialty treatments patient demographics pharmaceutical industry competitive landscape transformative therapies drug-delivery technologies regulatory strategy commercialization health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Greg Divis?

Greg Divis's verified email address is available on MessageCEO. They currently work at Avadel Pharmaceuticals plc. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Greg Divis lead?

Greg Divis is Chief Executive Officer at Avadel Pharmaceuticals plc, a company in the research sector with 220.0 employees. The company is based in Chesterfield, Missouri.

What industry is Greg Divis in?

Greg Divis works in the research industry as Chief Executive Officer at Avadel Pharmaceuticals plc. MessageCEO provides verified contact information for executives across all major industries.

Is Greg Divis's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Greg Divis's profile is kept up-to-date with the latest available information.

Last updated: April 17, 2026